Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS)
ICONS
Novel Biomarkers for Personalized Therapy in Korean Patients With Ischemic Stroke
1 other identifier
observational
581
1 country
1
Brief Summary
We hypothesized that paradoxical embolism may be one of the main mechanisms of silent cerebral infarction (SCI) located outside the perforating artery territory. In the present study, we evaluated the association between SCI and paradoxical embolism detected by agitated saline transcranial Doppler (TCD) monitoring in healthy subjects without history of stroke or transient ischemic attack (TIA). We also compared the frequency and amount of paradoxical embolism between healthy subjects with SCI and acute stroke patients with presumed cryptogenic embolism or conventional stroke mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 6, 2011
CompletedFirst Posted
Study publicly available on registry
September 7, 2011
CompletedSeptember 7, 2011
September 1, 2011
2.8 years
September 6, 2011
September 6, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency and amount of right-to-left shunts (RLS) on agitated saline TCD monitoring
Within a month after MRI scanning
Study Arms (3)
Case group
Healthy subjects with silent cerebral infarction
Control group 1
Patients with acute cryptogenic embolic stroke
Control group 2
Patients with acute stroke with conventional stroke mechanisms
Eligibility Criteria
Tertiary Hospital
You may qualify if:
- Healthy subjects
- Subjects with age over 20 years
- Subjects who consecutively visited a health promotion center for a health screening examination that included routine laboratory test, cardiac work-ups (12-lead electrocardiography and/or echocardiography), and brain magnetic resonance image (MRI) and MR angiography (MRA)
- Subjects who showed silent brain infarction (SCI) which was defined as a focal hyperintensity lesion 3 mm or large in diameter in the fluid-attenuation inversion recovery (FLAIR) images without a history of a corresponding stroke or transient ischemic attack (TIA)
- Subjects who performed agitated saline transcranial Doppler (TCD) monitoring
- Patients with acute stroke (both cryptogenic embolic stroke and conventional stroke mechanisms)
- Patients with age over 20 year
- Patients with focal neurologic deficits presented within 7 days of symptom onset
- Patients with acute ischemic lesions on diffusion-weighted image (DWI)
- Patients who performed agitated saline TCD monitoring
You may not qualify if:
- Healthy subjects
- Subjects with the presence of previous history of stroke or TIA
- Subjects with the presence of dementia on history taking or mini-mental status examination
- Subjects with the presence of proximal source of embolism, including atrial fibrillation or significant (≥50%) stenosis on cervicocerebral artery on MRA or carotid Duplex
- Subjects who had SCI restricted within perforator territory (basal ganglia or pons) suggesting that microangiopathy rather than embolism could be the main mechanism of SCI
- Subjects in whom agitated saline TCD monitoring was not performed or those who had poor temporal windows
- Patients with acute stroke (both cryptogenic embolic stroke and conventional stroke mechanisms)
- Patients in whom agitated saline TCD monitoring was not performed or those who had poor temporal windows
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center, Sungkyunkwan University
Seoul, 135710, South Korea
Related Publications (1)
Kim SJ, Shin HY, Ha YS, Kim JW, Kang KW, Na DL, Bang OY. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects). Eur J Neurol. 2013 Feb;20(2):353-60. doi: 10.1111/j.1468-1331.2012.03864.x. Epub 2012 Sep 9.
PMID: 22958084DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oh Young Bang, MD, PhD
Samsung Medical Center, Sungkyunkwan University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2011
First Posted
September 7, 2011
Study Start
April 1, 2008
Primary Completion
January 1, 2011
Study Completion
May 1, 2011
Last Updated
September 7, 2011
Record last verified: 2011-09